NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

ITC Q4 Results Expected to Show Subdued Performance Ahead of Earnings Announcement

ITC Limited, India's leading diversified conglomerate, is set to report its Q4FY26 results today, 21 May, 2026. The company's Board of Directors will meet to consider and approve the audited standalone and consolidated financial results for FY26, as well as a proposal for a final dividend for FY2026.

Ahead of the earnings announcement, the stock rose 0.9% to its day's high of ₹310.30 on the BSE. However, the stock has shed 5% in the past 3 months, 24% in the last 6 months, and 28% in the past 1 year.

According to brokerages, ITC's fast-moving consumer goods (FMCG) business is expected to maintain healthy growth momentum, but weakness in the cigarette and agri segments may keep overall revenue growth largely flat during the quarter.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

BrokerageExpected Revenue GrowthExpected EBITDA Growth
Nuvama Institutional EquitiesFlat-3.5%
Elara Securities-0.4%2%
Axis Securities5.2%2.9%

Analysts expect ITC to continue implementing calibrated cigarette price hikes over the coming months to fully offset the higher tax burden while protecting market share from illicit trade and downtrading. However, they note that the company is yet to achieve full pass-through of the recent tax increase, which may continue to impact cigarette volumes and profitability in the near term.

According to Nuvama Institutional Equities, cigarette net revenue and EBIT are likely to decline around 3% and 7%, respectively, during the March quarter. The brokerage expects cigarette volumes to remain flat compared to 7% growth in the December quarter and 5% growth in the year-ago period.

Despite weakness in cigarettes, Nuvama expects ITC's non-cigarette FMCG business to post nearly 10% revenue growth, aided by improving margins and favourable base effects. The brokerage also estimated that agribusiness revenue may decline around 10% year-on-year, although profits from the segment could still improve sharply due to margin recovery.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

In the December quarter, ITC reported a standalone net profit of ₹5,088.83 crore, down 6.1% year-on-year from ₹5,421.36 crore. Revenue from operations during Q3FY26 rose 5.8% year-on-year to ₹19,359.46 crore compared with ₹18,290.24 crore in the corresponding quarter last year.

Investors are likely to closely track management commentary around rural demand recovery, pricing actions in cigarettes, raw material cost trends, and the sustainability of margins across FMCG and agri businesses going forward.

Investor Takeaway

ITC's Q4 results may be subdued due to cigarette sales pressure, but its FMCG business is expected to maintain growth momentum.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.